Lipoedema and Weight Loss Injections (Mounjaro and Wegovy): A UK Doctor’s Guide

Uncategorized

October 19, 2026

Short answer: weight loss injections such as Mounjaro (tirzepatide) and Wegovy (semaglutide) can help many people with lipoedema lose weight, and some report less pain and heaviness. They are not licensed to treat lipoedema, there are no clinical trials in lipoedema yet, and the disproportionate lipoedema fat on the legs and arms usually remains after weight loss. This guide explains what the evidence shows, who can get these medicines in the UK, and what to think about if you are considering lipoedema surgery.

Written by Dr Edwin Anthony, Lead Clinician at Contoura Medical, a GMC registered doctor and Lipoedema UK Recognised Clinician who treats lipoedema at Langham Hospital, Marylebone. Last reviewed: October 2026.

Why this question matters

Since GLP-1 medicines became widely available in the UK, more of the women I see in clinic with lipoedema are either taking Mounjaro or Wegovy or asking whether they should. It is an understandable question. Many have spent years being told their legs would change if they simply ate less and exercised more, and these medicines are now producing large weight losses in people living with obesity.

The honest answer is more nuanced, because lipoedema and obesity are different conditions, even though they often occur together.

Lipoedema is not the same as obesity

Lipoedema is a chronic condition, almost always in women, where fat builds up symmetrically in the legs, hips and sometimes the arms, usually sparing the hands and feet. It is often painful, bruises easily and feels heavy. The 2024 German S2k lipoedema guideline states plainly that lipoedema is not caused by obesity and does not cause obesity. However, obesity is the most common condition found alongside lipoedema, and the guideline notes that obesity can make lipoedema worse.

This matters because weight loss medicines treat obesity. Where someone has both conditions, losing the obesity related weight can be very worthwhile for health, mobility and comfort. It does not follow that the lipoedema itself will resolve.

What does the evidence say about GLP-1 medicines in lipoedema?

At the time of writing there are no randomised controlled trials of GLP-1 or GIP/GLP-1 medicines in people with lipoedema. What we have is early and limited:

An online survey (2026). A large survey of people with lipedema, published in Obesity Pillars in August 2026 and initiated by the US Lipedema Foundation, found that participants reported better overall health and lower symptom severity while using these medicines. Results were self reported, participants chose to take part, and limb size was not measured, so it cannot tell us whether the lipoedema tissue itself changed.
A small case series (2025). Five women with lipoedema and insulin resistance treated off label with exenatide, an older GLP-1 medicine, for three to six months in Italy. Most lost some weight and reported less pain, and ultrasound fat thickness fell at most sites measured. There was no comparison group and diet and activity changed at the same time.
Individual case reports. Lipoedema UK has published a case study from a Norfolk lymphoedema service describing a woman with stage 2 lipoedema and type 2 diabetes who lost around 19 kg on Mounjaro and described her legs as softer and less painful. Limb volume was not measured.

Lipoedema UK describes the research as very limited and notes these medicines are not licensed or approved for lipoedema. A UK study at City St George’s, University of London, is currently surveying people with lipoedema who have used these medicines, which should add useful data.

Why the legs often do not change as much as the rest of the body

The best evidence on this question comes from bariatric (weight loss) surgery, which produces even larger weight losses than injections. A 2025 scoping review in Obesity Surgery looked at 49 women with lipoedema who had bariatric surgery. On average they lost about 71% of their excess weight, yet their pain scores did not improve, and limb circumference reduced only modestly in some patients.

In practice, this is the pattern I see. Weight loss slims the abdomen, face and upper body, while the lipoedema fat on the hips, thighs, knees and calves changes far less. The disproportion can become more noticeable, not less. That is not a failure of willpower or of the medicine; it reflects the nature of lipoedema tissue.

Can you get Mounjaro or Wegovy on the NHS for lipoedema?

A lipoedema diagnosis on its own does not make you eligible. NHS access follows NICE guidance for weight management:

Wegovy (semaglutide), NICE TA875: generally a BMI of 35 or more, or 30 to 34.9 with qualifying criteria, plus at least one weight related condition, prescribed within a specialist weight management service for up to two years. Lower BMI thresholds usually apply to some ethnic groups.
Mounjaro (tirzepatide), NICE TA1026: a BMI of 35 or more with at least one weight related condition. GP prescribing began in June 2025 and is being phased in, starting with people who have a BMI of 40 or more and several weight related conditions.

Many people with lipoedema therefore buy these medicines privately. If you do, the MHRA advises getting them only on prescription from a legitimate UK pharmacy, checking the pharmacy is registered with the General Pharmaceutical Council, and never buying from social media or unregulated websites. The MHRA has issued alerts about fake Mounjaro pens.

Safety points every woman should know

Contraception: Mounjaro can make the oral contraceptive pill less reliable. The MHRA advises adding a barrier method for four weeks after starting and for four weeks after each dose increase, or using a non oral method such as a coil or implant.
Pregnancy: do not use these medicines in pregnancy or while breastfeeding. Stop tirzepatide at least one month, and semaglutide at least two months, before trying to conceive.
Pancreatitis: in January 2026 the MHRA strengthened its warnings about acute pancreatitis, including rare severe and fatal cases. Seek urgent help for severe, persistent stomach pain that may spread to your back.
Muscle loss: rapid weight loss includes some lean tissue as well as fat. In a body composition substudy of the SURMOUNT-1 trial, around a quarter of the weight lost on tirzepatide was lean mass. Adequate protein and strength exercise help protect muscle.
Cosmetic use: the MHRA is clear these medicines are not for weight loss for purely aesthetic reasons.

If you are considering lipoedema surgery

For many women, weight loss medicine and lipoedema surgery are not either or choices. Reducing any coexisting obesity first can make surgery safer and the result more predictable. A few practical points:

Stable weight first. Surgeons generally prefer your weight to have settled before liposuction, so the result is not changed by further large weight loss afterwards. Germany’s statutory insurers, for example, now fund lipoedema liposuction but require a relatively stable weight and six months of conservative treatment. There is no evidence based figure for exactly how long to wait, so this is an individual decision with your surgeon.
Tell your anaesthetist. GLP-1 medicines slow stomach emptying, which can matter under anaesthesia or sedation. A 2025 UK multidisciplinary consensus endorsed by the Association of Anaesthetists and the Centre for Perioperative Care advises that most patients can continue these medicines through surgery, with the anaesthetic team assessing each person’s risk. Do not stop or restart doses without advice, and follow the instructions you are given before your procedure.
Skin quality. Rapid weight loss can leave looser skin. This is assessed at consultation, as it can influence the technique used and whether skin tightening is worth considering.
The goal of surgery. Lipoedema surgery aims to remove the diseased fat that does not respond well to weight loss, improving pain, heaviness, mobility and proportion. It is not a weight loss operation.

Questions to ask your doctor

Do I have lipoedema, obesity, or both, and how was that assessed?
Am I eligible for an NHS weight management service?
If I take a GLP-1 medicine privately, who will monitor me and how?
What results can I realistically expect in my legs and arms?
How long should my weight be stable before surgery, and what should I do with my medicine around the operation?

The bottom line

GLP-1 and GIP/GLP-1 medicines can be genuinely helpful for women with lipoedema who also live with obesity, and some report less pain. They are not a treatment for lipoedema itself, the evidence in lipoedema is still very early, and the lipoedema fat usually remains. Used safely, under proper prescribing, they can be one part of a plan that also includes compression, movement, good nutrition and, where appropriate, specialist surgery.

If you would like a specialist assessment, Dr Edwin Anthony sees patients with lipoedema at Langham Hospital, 77 Hallam Street, Marylebone, London W1W 5HB. You can read more about lipoedema treatment in London, see our prices, or book a consultation. For independent information and support, visit Lipoedema UK.

This article is general information and does not replace individual medical advice. Please speak to your own doctor before starting, stopping or changing any medicine.

Sources

Dr Edwin Anthony

Lead Clinician

Dr Edwin Anthony, Lead Clinician. Specialist in Advanced Body Contouring, Lipoedema, and Aesthetic Surgery London, United Kingdom Professional Overview Dr Edwin Anthony is a highly accomplished, London-born cosmetic surgeon and aesthetic doctor with over 14 years of dedicated experience in high-definition body sculpting, minimally invasive aesthetic procedures, and specialized surgical conditions. Renowned for his precise technical skill and artistic approach to human anatomy, Dr Anthony has performed more than 1,500 advanced VASER liposuction procedures. He practises full-time at Langham Hospital, 77 Hallam Street, Marylebone, London W1W 5HB. Education and Surgical Foundation Dr Anthony’s rigorous medical training began at Trinity College Dublin, where he graduated with his medical degrees (MB BCh BAO) in 1999. He built a exceptionally strong surgical foundation during his early career, rotating through some of the UK's most prestigious NHS plastic surgery and surgical units, including: Barts and The London NHS Trust Guy’s and St Thomas’ NHS Trust St George’s Hospital Broomfield Hospital Following his core training, he achieved his postgraduate qualification to become a Member of the Royal College of Surgeons of Edinburgh (MRCS Ed). Driven by a deep interest in tissue healing and skin architecture, he also completed advanced postgraduate research on keloid scarring and topical drug delivery at the Centre for Cutaneous Research, Queen Mary University of London. Specialisms and Technological Innovation Dr Anthony transitioned fully into private aesthetic and cosmetic surgery in 2009. He is recognised as one of the UK’s premier authorities in Vaser liposuction, having trained directly under the legendary Dr Alfredo Hoyos, the global pioneer of VASER Hi-Definition Liposculpture. Dr Anthony is fully certified on the elite TOTAL DEFINER platform for Advanced 4D Lipo Training. His surgical and clinical practice focuses heavily on: Advanced VASER 4D Lipo & Body Contouring: Utilising PAL and VASER ultrasound technology to elegantly fragment fat while cleanly preserving vital vascular and lymphatic networks. Lipoedema Surgical Care: Providing transformative, medically necessary body contouring to alleviate the physical and functional challenges of Lipoedema. Gynaecomastia Surgery: Reshaping and defining the male chest profile. Subdermal Skin Tightening Combinations: He was one of the first practitioners in Europe to integrate Renuvion (J-Plasma) technology, and regularly pairs liposuction with advanced energy matrices like Quantum RF, BodyTite Turbo, and FaceTite Turbo to manage skin laxity (particularly after significant natural weight loss or GLP-1 medication-related changes). Clinical Philosophy and Memberships Dr Anthony’s practice is built entirely on the principle that body contouring is an art of redefining structural proportions rather than simple fat reduction. Known for his honest, patient-centric consultation style, he works closely with patients to create subtle, balanced, and deeply natural-looking results that harmonise with their intrinsic frames. His elite reputation attracts a diverse national and international clientele, including high-profile personalities and members of global royal households. He maintains active alignments with leading global surgical frameworks: General Medical Council (GMC) – Fully Registered with a License to Practice Royal College of Surgeons of Edinburgh (Member) International Lipoedema Association (ILA) (Physician Member) Lipoedema UK (Clinician Member) British Association of Cosmetic Surgeons (BACS)

26 articles publishedExpertise: Vaser lipo, HD Lipo, QuantumRF, Renuvion